Meet the Cohort 2018/19
Operon (formerly Coli)
Multiplatform lab work management application
Operon aims to improve the efficiency of science with software. Science is held back by the way scientists manage their lab work. Operon is a multiplatform ELN application to easily set up, execute and record experiments from the desktop to the bench-top. Unlike competitors, it is both easy-to-use and ready for bench-top integration.
Reza Rohani
(Team Lead)
PhD Bioengineering
Serbald Verkuijl
(Product)
PhD Interdisciplinary Biosciences
Stefan Leape (Business)
MSc Biochemistry undergraduate
AllGood
Elderly care app that helps you checks on loved ones
AllGood was founded on the belief that families shouldn't have to worry about their elderly loved ones living alone. All current solutions entail functional, emotional, and economic compromises. As 40% of seniors have a smartphone, AllGood decided to solve this problem with a simple mobile application. It provides an alternative to obsolete panic buttons (of which half are never worn).
Maggie Chen
MPhil Languages undergraduate
Carlo Quadrio Curzio
BA Human Sciences
Benjamin Griffiths
DPhil Quantum Physics
Daniel Ma
BSc Computer Science
Neurolytics (formerly Rebndl)
Intelligent digital news subscription
Rebndl is on the verge of transforming the news publishing industry. Currently, 67% of people read the news online for free, and are increasingly looking to access a highly curated selection of news stories on their smartphones. Through its digital news subscription platform, Rebndl integrates the emerging trends in news consumption behaviour with the changing business demands of newspapers to shape the future of news publishing.
After having been equipped with the skills needed to found a start-up in the OX1 Incubator, the original Rebndl team moved on to a new idea: Neurolytic Healthcare Ltd. They have already received funding from two sources and have a headcount of 10 dedicated team members including a prominent advisory board.
Neurolytic Healthcare Ltd. delivers AI-driven real-time event prediction and pharmacogenomic testing for neurological disorders to improve patient quality of life and help clinicians optimise prescription decisions. It draws on recent advances and successes in personalised medicine and pharmacogenomics, supported by NHS England's aim to embed personalised healthcare across the NHS. Given the current suboptimal management of neurological disorders and lack of specialised healthcare staff in the UK, there remains a significant unmet need for digital healthcare providers who can deliver effective neurological event prediction prediction tools and a systematic optimisation of pharmacological treatment. By covering and personalising the complete treatment pathway, Neurolytic Healthcare ensures improved quality of life and optimised clinical decision-making, whilst reducing the significant costs to the economy and healthcare system.
Roman Rothärmel
DPhil Neuroscience
Tom Kent
DPhil Medical Science
Artale
Art marketplace platform developing limited editions of art derivatives
The Chinese Authorised Art Derivatives market has an estimated size of 10 billion USD. Yet, it still has untapped opportunities. Artale addresses four primary issues faced by artists (lack of knowledge of how to monetise their art beyond galleries; lack of motivation to seek potential buyers; no market for the transactions of mid-tier artists’ works; and limited digital means to display and sell their art) and two issues faced by customers (middle income families do not have sufficient income to purchase high end artworks; and many potential customers are unaware of the range of offerings of the art market).
Lucy Li
BA Economics and Management undergraduate
Lena Ma
MBA
Helen Chan
British and European studies
Intrepidus
App using CBT to overcome the fear of needles
The current solutions to a fear of needs (talking therapies, distraction and relaxation) are either ineffective or expensive and inconvenient. Intrepidus provides convenient, low-cost, therapy-quality care to help people overcome their fear of needles. It does so via an app powered by AI and CBT which identifies and challenges patients’ fears and unhelpful thoughts and behaviours.
Zaki Krag Nielsen
DPhil Medical Sciences
Vlad Moldoveanu
MSc Mathematics and Computer Science
Ceres
Fresh pasta making robot
Ceres tackles the ‘hungry person’s trilemma’: when choosing between convenient, affordable and healthy food, you can generally have at most two of the three. This trilemma is most noteworthy during the lunchtime rush, which presents a lucrative opportunity: the lunchtime market in the UK is £5 billion per annum and growing.
Ceres is creating a high-end pasta making robot that can deliver a fresh pasta meal from order to service in less than 3 minutes.
OX1 Incubator Demo Day 2024
Meet entrepreneurship experts & watch a selection of our cohort's startups pitch for a chance to win £18k in prize money.
Time & Location
Apr 27, 2024, 10:00 AM – 12:00 PM
Oxford, Park End St, Oxford OX1 1HP, UK
About the event
Watch some of the most exciting startups coming out of Oxford pitch at our annual Demo Day! Stay for an opportunity to network with enterpreneurship experts, investors and others interested in startups.
Said Business School, Rhodest Trust Lecture Theatre
Oxford OX1 1HP
Please arrive 5 minutes early.
Tickets
General Ticket
Ticket includes free catering.
£0.00Sale ended
Total
£0.00